Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 1A receptor (5-HT1A) is a subtype of serotonin receptors, part of the G protein-coupled receptor (GPCR) family. It binds the neurotransmitter serotonin (5-hydroxytryptamine, or 5-HT). It primarily couples to Gi/Go proteins, inhibiting adenylyl cyclase activity and activating inwardly rectifying potassium channels. 5-HT1A receptors are found as autoreceptors on serotonergic neurons in the raphe nuclei and as heteroreceptors on postsynaptic neurons elsewhere in the brain. It is involved in mood, anxiety, cognition, and hormone secretion and is a target for antidepressants and anxiolytics.
Agonism (anxiolytic/antidepressant), Antagonism (cognitive enhancement), Indirect modulation via increased synaptic serotonin availability (SSRIs)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin receptor 1A (5-hydroxytryptamine receptor 1A) (5-HT1A).